<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">18362103</PMID>
      <DateCompleted>
        <Year>2008</Year>
        <Month>06</Month>
        <Day>10</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>10</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1521-0111</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>73</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2008</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Molecular pharmacology</Title>
          <ISOAbbreviation>Mol Pharmacol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>A cAMP-dependent, protein kinase A-independent signaling pathway mediating neuritogenesis through Egr1 in PC12 cells.</ArticleTitle>
        <Pagination>
          <StartPage>1688</StartPage>
          <EndPage>1708</EndPage>
          <MedlinePgn>1688-708</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1124/mol.107.044792</ELocationID>
        <Abstract>
          <AbstractText>The neurotrophic peptide PACAP (pituitary adenylate cyclase-activating polypeptide) elevates cAMP in PC12 cells. Forskolin and dibutyryl cAMP mimic PACAP's neuritogenic and cell morphological effects, suggesting that they are driven by cAMP. Comparison of microarray expression profiles after exposure of PC12 cells to either forskolin, dibutyryl cAMP, or PACAP revealed a small group of cAMP-dependent target genes. Neuritogenesis induced by all three agents is protein kinase A (PKA)-independent [not blocked by N-[2-(4-bromocinnamylamino)ethyl]-5-isoquinoline (H89)] and extracellular signal-regulated kinase (ERK)-dependent [blocked by 1,4-diamino-2,3-dicyano-1,4-bis(methylthio) butadiene (U0126)], and therefore cAMP-dependent target genes potentially mediating neuritogenesis were selected for further analysis based on the pharmacological profile of their induction by PACAP (i.e., mimicking that of neuritogenesis). Small interfering RNA (siRNA) targeting one of these genes, Egr1, blocked PACAP-induced neuritogenesis, and siRNA targeting another, Vil2, blocked a component of the cell size increase elicited by PACAP. Neither siRNA blocked PACAP's PKA-dependent antiproliferative effects. PACAP signaling to neuritogenesis was also impaired by dominant-negative Rap1 expression but was not affected by inhibition of protein kinase C (PKC), indicating a G-protein-coupled receptor-mediated differentiation pathway distinct from the one activated by receptor tyrosine kinase ligands such as nerve growth factor (NGF), that involves both Rap1 and PKC. We have thus identified a cAMP-dependent, PKA-independent pathway proceeding through ERK that functions to up-regulate the transcription of two genes, Egr1 and Vil2, required for PACAP-dependent neuritogenesis and increased cell size, respectively. Dominant-negative Rap1 expression impairs both PACAP-induced neuritogenesis and Egr1 activation by PACAP, suggesting that cAMP elevation and ERK activation by PACAP are linked through Rap1.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ravni</LastName>
            <ForeName>Aurélia</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Section on Molecular Neuroscience, National Institute of Mental Health, Bethesda, MD 20892, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vaudry</LastName>
            <ForeName>David</ForeName>
            <Initials>D</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gerdin</LastName>
            <ForeName>Matthew J</ForeName>
            <Initials>MJ</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Eiden</LastName>
            <ForeName>Maribeth V</ForeName>
            <Initials>MV</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Falluel-Morel</LastName>
            <ForeName>Anthony</ForeName>
            <Initials>A</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Gonzalez</LastName>
            <ForeName>Bruno J</ForeName>
            <Initials>BJ</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Vaudry</LastName>
            <ForeName>Hubert</ForeName>
            <Initials>H</Initials>
          </Author>
          <Author ValidYN="Y">
            <LastName>Eiden</LastName>
            <ForeName>Lee E</ForeName>
            <Initials>LE</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>Z01 MH002386</GrantID>
            <Acronym>ImNIH</Acronym>
            <Agency>Intramural NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>Z01 MH002386-21</GrantID>
            <Acronym>ImNIH</Acronym>
            <Agency>Intramural NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>Z01 MH002386-22</GrantID>
            <Acronym>ImNIH</Acronym>
            <Agency>Intramural NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>ZIA MH002386-23</GrantID>
            <Acronym>ImNIH</Acronym>
            <Agency>Intramural NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D003160">Comparative Study</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2008</Year>
          <Month>03</Month>
          <Day>24</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Mol Pharmacol</MedlineTA>
        <NlmUniqueID>0035623</NlmUniqueID>
        <ISSNLinking>0026-895X</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D051766">Early Growth Response Protein 1</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C486110">Egr1 protein, rat</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D051219">Pituitary Adenylate Cyclase-Activating Polypeptide</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.11</RegistryNumber>
          <NameOfSubstance UI="D017868">Cyclic AMP-Dependent Protein Kinases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017868" MajorTopicYN="N">Cyclic AMP-Dependent Protein Kinases</DescriptorName>
          <QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051766" MajorTopicYN="N">Early Growth Response Protein 1</DescriptorName>
          <QualifierName UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016501" MajorTopicYN="N">Neurites</DescriptorName>
          <QualifierName UI="Q000201" MajorTopicYN="Y">enzymology</QualifierName>
          <QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016716" MajorTopicYN="N">PC12 Cells</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051219" MajorTopicYN="N">Pituitary Adenylate Cyclase-Activating Polypeptide</DescriptorName>
          <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2008</Year>
          <Month>3</Month>
          <Day>26</Day>
          <Hour>9</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2008</Year>
          <Month>6</Month>
          <Day>11</Day>
          <Hour>9</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2008</Year>
          <Month>3</Month>
          <Day>26</Day>
          <Hour>9</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">18362103</ArticleId>
        <ArticleId IdType="mid">NIHMS631296</ArticleId>
        <ArticleId IdType="pmc">PMC4188547</ArticleId>
        <ArticleId IdType="doi">10.1124/mol.107.044792</ArticleId>
        <ArticleId IdType="pii">mol.107.044792</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Barrie AP, Clohessy AM, Buensuceso CS, Rogers MV, Allen JM. Pituitary adenylyl cyclase-activating peptide stimulates extracellular signal-regulated kinase 1 or 2 (ERK1/2) activity in a ras-independent, mitogen-activated protein kinase/ERK kinase 1 or 2-dependent manner in PC12 cells. J Biol Chem. 1997;272:19666–19671.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9242621</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bouschet T, Perez V, Fernandez C, Bockaert J, Eychene A, Journot L. Stimulation of the ERK pathway by GTP-loaded Rap1 requires the concomitant activation of Ras, protein kinase C, and protein kinase A in neuronal cells. J Biol Chem. 2003;278:4778–4785.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12473665</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen Y, Samal B, Hamelink CR, Xiang CC, Chen Y, Chen M, Vaudry D, Brownstein MJ, Hallenbeck JM, Eiden LE. Neuroprotection by endogenous and exogenous PACAP following stroke. Regul Pept. 2006;137:4–19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4183206</ArticleId>
            <ArticleId IdType="pubmed">17027094</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Corbitt J, Vivekananda J, Wang SS, Strong R. Transcriptional and posttranscriptional control of tyrosine hydroxylase gene expression during persistent stimulation of pituitary adenylate cyclase-activating polypeptide receptors on PC12 cells: Regulation by protein kinase A-dependent and protein kinase A-independent pathways. J Neurochem. 1998;71:478–486.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9681437</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Craig SW, Powell LD. Regulation of actin polymerization by villin, a 95,000 dalton cytoskeletal component of intestinal brush borders. Cell. 1980;22:739–746.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6893953</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Das KP, Freudenrich TM, Mundy WR. Assessment of PC12 cell differentiation and neurite growth: a comparison of morphological and neurochemical measures. Neurotoxicol Teratol. 2004;26:397–406.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15113601</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deutsch PJ, Sun Y. The 38-amino acid form of pituitary adenylate cyclase-activating polypeptide stimulates dual signaling cascades in PC12 cells and promotes neurite outgrowth. J Biol Chem. 1992;267:5108–5113.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1312085</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gerdin MJ, Eiden LE. Regulation of PC12 cell differentiation by cAMP signaling to ERK independent of PKA: do all the connections add up? Sci STKE. 2007:pe15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4183209</ArticleId>
            <ArticleId IdType="pubmed">17440132</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ginty DD, Fanger GR, Wagner JA, Maue RA. The activity of cAMP-dependent protein kinase is required at a posttranslational level for induction of voltage-dependent sodium channels by peptide growth factors in PC12 cells. J Cell Biol. 1992;116:1465–1473.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2289385</ArticleId>
            <ArticleId IdType="pubmed">1311713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ginty DD, Glowacka D, DeFranco C, Wagner JA. Nerve growth factor-induced neuronal differentiation after dominant repression of both type I and type II cAMP-dependent protein kinase activities. J Biol Chem. 1991;266:15325–15333.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1651325</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Greene LA, Tischler AS. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci U S A. 1976;73:2424–2428.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC430592</ArticleId>
            <ArticleId IdType="pubmed">1065897</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Grumolato L, Louiset E, Alexandre D, Ait-Ali D, Turquier V, Fournier A, Fasolo A, Vaudry H, Anouar Y. PACAP and NGF regulate common and distinct traits of the sympathoadrenal lineage: effects on electrical properties, gene markers and transcription factors in differentiating PC12 cells. Eur J Neurosci. 2003;17:71–82.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12534970</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hamelink C, Lee HW, Chen Y, Grimaldi M, Eiden LE. Coincident elevation of cAMP and calcium influx by PACAP-27 synergistically regulates vasoactive intestinal polypeptide gene transcription through a novel PKA-independent signaling pathway. J Neurosci. 2002;22:5310–5320.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6758207</ArticleId>
            <ArticleId IdType="pubmed">12097482</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harada T, Morooka T, Ogawa S, Nishida E. ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1. Nat Cell Biol. 2001;3:453–459.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11331872</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harmar AJ, Arimura A, Gozes I, Journot L, Laburthe M, Pisegna JP, Rawlings SR, Robberecht P, Said SI, Sreedharan SP, et al.  International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev. 1998;50:265–270.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6721840</ArticleId>
            <ArticleId IdType="pubmed">9647867</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hughes AL, Messineo-Jones D, Lad SP, Neet KE. Distinction between differentiation, cell cycle, and apoptosis signals in PC12 cells by the nerve growth factor mutant delta9/13, which is selective for the p75 neurotrophin receptor. J Neurosci Res. 2001;63:10–19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11169609</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kienlen Campard P, Crochemore C, René F, Koch B, Loeffler JP. PACAP type I receptor activation promotes cerebellar neuron survival through the cAMP/ PKA signaling pathway. DNA Cell Biol. 1997;16:323–333.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9115641</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lazarovici P, Jiang H, Fink D., Jr The 38-amino-acid form of pituitary adenylate cyclase-activating polypeptide induces neurite outgrowth in PC12 cells that is dependent on protein kinase C and extracellular signal-regulated kinase but not on protein kinase A, nerve growth factor receptor tyrosine kinase, p21ras G protein, and pp60c-src cytoplasmic tyrosine kinase. Mol Pharmacol. 1998;54:547–558.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9730914</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Levkovitz Y, Baraban JM. A dominant negative Egr inhibitor blocks nerve growth factor-induced neurite outgrowth by suppressing c-Jun activation: role of an Egr/c-Jun complex. J Neurosci. 2002;22:3845–3854.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6757642</ArticleId>
            <ArticleId IdType="pubmed">12019303</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>MacCormick M, Moderscheim T, van der Salm LW, Moore A, Pryor SC, McCaffrey G, Grimes ML. Distinct signalling particles containing Erk/Mek and B-Raf in PC12 cells. Biochem J. 2005;387:155–164.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1134943</ArticleId>
            <ArticleId IdType="pubmed">15500439</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Obara Y, Labudda K, Dillon TJ, Stork PJ. PKA phosphorylation of Src mediates Rap1 activation in NGF and cAMP signaling in PC12 cells. J Cell Sci. 2004;117:6085–6094.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15546918</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ohtaki H, Nakamachi T, Dohi K, Aizawa Y, Takaki A, Hodoyama K, Yofu S, Hashimoto H, Shintani N, Baba A, et al.  Pituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6. Proc Natl Acad Sci U S A. 2006;103:7488–7493.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1464366</ArticleId>
            <ArticleId IdType="pubmed">16651528</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Osipenko ON, Barrie AP, Allen JM, Gurney AM. Pituitary adenylyl cyclase-activating peptide activates multiple intracellular signaling pathways to regulate ion channels in PC12 cells. J Biol Chem. 2000;275:16626–16631.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10748146</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qiu J, Cai D, Filbin MT. A role for cAMP in regeneration during development and after injury. Prog Brain Res. 2002;137:381–387.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12440380</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rausch DM, Iacangelo AL, Eiden LE. Glucocorticoid- and nerve growth factor-induced changes in chromogranin A expression define two different neuronal phenotypes in PC12 cells. Mol Endocrinol. 1988;2:921–927.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3185567</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ravenall SJ, Gavazzi I, Wood JN, Akopian AN. A peripheral nervous system actin-binding protein regulates neurite outgrowth. Eur J Neurosci. 2002;15:281–290.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11849295</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ravni A, Eiden LE, Vaudry H, Gonzalez BJ, Vaudry D. Cycloheximide treatment to identify components of the transitional transcriptome in PACAP-induced PC12 cell differentiation. J Neurochem. 2006;98:1229–1241.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4183198</ArticleId>
            <ArticleId IdType="pubmed">16787409</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reglodi D, Somogyvari-Vigh A, Vigh S, Kozicz T, Arimura A. Delayed systemic administration of PACAP38 is neuroprotective in transient middle cerebral artery occlusion in the rat. Stroke. 2000;31:1411–1417.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10835464</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Robinson MJ, Stippec SA, Goldsmith E, White MA, Cobb MH. A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation. Curr Biol. 1998;8:1141–1150.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9799732</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shibata M, Ishii J, Koizumi H, Shibata N, Dohmae N, Takio K, Adachi H, Tsujimoto M, Arai H. Type F scavenger receptor SREC-I interacts with advillin, a member of the gelsolin/villin family, and induces neurite-like outgrowth. J Biol Chem. 2004;279:40084–40090.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15247299</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stessin AM, Zippin JH, Kamenetsky M, Hess KC, Buck J, Levin LR. Soluble adenylyl cyclase mediates nerve growth factor-induced activation of Rap1. J Biol Chem. 2006;281:17253–17258.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3092367</ArticleId>
            <ArticleId IdType="pubmed">16627466</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tanaka J, Koshimura K, Murakami Y, Kato Y. Stimulatory effect of PACAP on neuronal cell survival. Ann N Y Acad Sci. 1996;805:473–475.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8993426</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Taupenot L, Mahata M, Mahata SK, O’Connor DT. Time-dependent effects of the neuropeptide PACAP on catecholamine secretion. Stimulation and desensitization. Hypertension. 1999;34:1152–1162.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10567198</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vaudry D, Chen Y, Ravni A, Hamelink C, Elkahloun AG, Eiden LE. Analysis of the PC12 cell transcriptome after differentiation with pituitary adenylate cyclase-activating polypeptide (PACAP) J Neurochem. 2002a;83:1272–1284.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4186721</ArticleId>
            <ArticleId IdType="pubmed">12472882</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vaudry D, Stork PJ, Lazarovici P, Eiden LE. Signaling pathways for PC12 cell differentiation: making the right connections. Science. 2002b;296:1648–1649.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12040181</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vossler MR, Yao H, York RD, Pan M-G, Rim CS, Stork PJS. cAMP activates MAP kinase and elk-1 through a B-raf and rap1-dependent pathway. Cell. 1997;89:73–82.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9094716</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Z, Dillon TJ, Pokala V, Mishra S, Labudda K, Hunter B, Stork PJ. Rap1-mediated activation of extracellular signal-regulated kinases by cyclic AMP is dependent on the mode of Rap1 activation. Mol Cell Biol. 2006;26:2130–2145.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1430276</ArticleId>
            <ArticleId IdType="pubmed">16507992</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yao H, York RD, Misra-Press A, Carr DW, Stork PJS. The cyclic adenosine monophosphate-dependent protein kinase (PKA) is required for the sustained activation of mitogen-activated kinases and gene expression by nerve growth factor. J Biol Chem. 1998;273:8240–8247.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9525930</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>York RD, Yao H, Dillon T, Ellig CL, Eckert SP, McCleskey EW, Stork PJS. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature. 1998;392:622–626.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9560161</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Young SW, Dickens M, Tavare JM. Differentiation of PC12 cells in response to a cAMP analogue is accompanied by sustained activation of mitogen-activated protein kinase. Comparison with the effects of insulin, growth factors and phorbol esters. FEBS Lett. 1994;338:212–216.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">8307183</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
